BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 15832312)

  • 21. Analysis of gene mutations of medium-chain acyl-coenzyme a dehydrogenase deficiency (MCADD) by next-generation sequencing in Henan, China.
    Tian Y; Zhu X; Lv S; Jia C; Zhang L; Ni M; Xu Y; Peng R; Liu S; Zhao D
    Clin Chim Acta; 2022 Nov; 536():155-161. PubMed ID: 36096209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medium-chain acyl-CoA deficiency: outlines from newborn screening, in silico predictions, and molecular studies.
    Catarzi S; Caciotti A; Thusberg J; Tonin R; Malvagia S; la Marca G; Pasquini E; Cavicchi C; Ferri L; Donati MA; Baronio F; Guerrini R; Mooney SD; Morrone A
    ScientificWorldJournal; 2013; 2013():625824. PubMed ID: 24294134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medium-Chain Acyl-CoA Dehydrogenase Deficiency: Evaluation of Genotype-Phenotype Correlation in Patients Detected by Newborn Screening.
    Gramer G; Haege G; Fang-Hoffmann J; Hoffmann GF; Bartram CR; Hinderhofer K; Burgard P; Lindner M
    JIMD Rep; 2015; 23():101-12. PubMed ID: 25940036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Newborn screening for medium-chain acyl-CoA dehydrogenase deficiency: regional experience and high incidence of carnitine deficiency.
    Couce ML; Sánchez-Pintos P; Diogo L; Leão-Teles E; Martins E; Santos H; Bueno MA; Delgado-Pecellín C; Castiñeiras DE; Cocho JA; García-Villoria J; Ribes A; Fraga JM; Rocha H
    Orphanet J Rare Dis; 2013 Jul; 8():102. PubMed ID: 23842438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical, biochemical and genetic analyses in two Korean patients with medium-chain acyl-CoA dehydrogenase deficiency.
    Woo HI; Park HD; Lee YW; Lee DH; Ki CS; Lee SY; Kim JW
    Korean J Lab Med; 2011 Jan; 31(1):54-60. PubMed ID: 21239873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 221 newborn-screened neonates with medium-chain acyl-coenzyme A dehydrogenase deficiency: Findings from the Inborn Errors of Metabolism Collaborative.
    Bentler K; Zhai S; Elsbecker SA; Arnold GL; Burton BK; Vockley J; Cameron CA; Hiner SJ; Edick MJ; Berry SA;
    Mol Genet Metab; 2016 Sep; 119(1-2):75-82. PubMed ID: 27477829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The first three years of screening for medium chain acyl-CoA dehydrogenase deficiency (MCADD) by newborn screening ontario.
    Kennedy S; Potter BK; Wilson K; Fisher L; Geraghty M; Milburn J; Chakraborty P
    BMC Pediatr; 2010 Nov; 10():82. PubMed ID: 21083904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and mutation analysis of short/branched chain acyl-CoA dehydrogenase deficiency (SBCADD) detected on newborn screening in Wisconsin.
    Van Calcar SC; Baker MW; Williams P; Jones SA; Xiong B; Thao MC; Lee S; Yang MK; Rice GM; Rhead W; Vockley J; Hoffman G; Durkin MS
    Mol Genet Metab; 2013; 110(1-2):111-5. PubMed ID: 23712021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and biochemical outcomes of patients with medium-chain acyl-CoA dehydrogenase deficiency.
    Anderson DR; Viau K; Botto LD; Pasquali M; Longo N
    Mol Genet Metab; 2020 Jan; 129(1):13-19. PubMed ID: 31836396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MS/MS-based newborn and family screening detects asymptomatic patients with very-long-chain acyl-CoA dehydrogenase deficiency.
    Spiekerkoetter U; Sun B; Zytkovicz T; Wanders R; Strauss AW; Wendel U
    J Pediatr; 2003 Sep; 143(3):335-42. PubMed ID: 14517516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genotype and residual enzyme activity in medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: Are predictions possible?
    Tucci S; Wagner C; Grünert SC; Matysiak U; Weinhold N; Klein J; Porta F; Spada M; Bordugo A; Rodella G; Furlan F; Sajeva A; Menni F; Spiekerkoetter U
    J Inherit Metab Dis; 2021 Jul; 44(4):916-925. PubMed ID: 33580884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medium-chain acyl-CoA dehydrogenase (MCAD) mutations identified by MS/MS-based prospective screening of newborns differ from those observed in patients with clinical symptoms: identification and characterization of a new, prevalent mutation that results in mild MCAD deficiency.
    Andresen BS; Dobrowolski SF; O'Reilly L; Muenzer J; McCandless SE; Frazier DM; Udvari S; Bross P; Knudsen I; Banas R; Chace DH; Engel P; Naylor EW; Gregersen N
    Am J Hum Genet; 2001 Jun; 68(6):1408-18. PubMed ID: 11349232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Newborn screening for medium chain acyl CoA dehydrogenase deficiency.
    Leonard JV; Dezateux C
    Arch Dis Child; 2009 Mar; 94(3):235-8. PubMed ID: 18838415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maternal medium-chain acyl-CoA dehydrogenase deficiency identified by newborn screening.
    Leydiker KB; Neidich JA; Lorey F; Barr EM; Puckett RL; Lobo RM; Abdenur JE
    Mol Genet Metab; 2011 May; 103(1):92-5. PubMed ID: 21354840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequencing from dried blood spots in infants with "false positive" newborn screen for MCAD deficiency.
    McCandless SE; Chandrasekar R; Linard S; Kikano S; Rice L
    Mol Genet Metab; 2013 Jan; 108(1):51-5. PubMed ID: 23151387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel molecular aspect of Japanese patients with medium-chain acyl-CoA dehydrogenase deficiency (MCADD): c.449-452delCTGA is a common mutation in Japanese patients with MCADD.
    Purevsuren J; Kobayashi H; Hasegawa Y; Mushimoto Y; Li H; Fukuda S; Shigematsu Y; Fukao T; Yamaguchi S
    Mol Genet Metab; 2009 Feb; 96(2):77-9. PubMed ID: 19064330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutations of ACADS gene associated with short-chain acyl-coenzyme A dehydrogenase deficiency.
    Kim SH; Park HD; Sohn YB; Park SW; Cho SY; Ji S; Kim SJ; Choi EW; Kim CH; Ko AR; Yeau S; Paik KH; Jin DK
    Ann Clin Lab Sci; 2011; 41(1):84-8. PubMed ID: 21325261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genotypic differences of MCAD deficiency in the Asian population: novel genotype and clinical symptoms preceding newborn screening notification.
    Ensenauer R; Winters JL; Parton PA; Kronn DF; Kim JW; Matern D; Rinaldo P; Hahn SH
    Genet Med; 2005; 7(5):339-43. PubMed ID: 15915086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid, comprehensive screening of the human medium chain acyl-CoA dehydrogenase gene.
    McKinney JT; Longo N; Hahn SH; Matern D; Rinaldo P; Strauss AW; Dobrowolski SF
    Mol Genet Metab; 2004 Jun; 82(2):112-20. PubMed ID: 15171998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein misfolding is the molecular mechanism underlying MCADD identified in newborn screening.
    Maier EM; Gersting SW; Kemter KF; Jank JM; Reindl M; Messing DD; Truger MS; Sommerhoff CP; Muntau AC
    Hum Mol Genet; 2009 May; 18(9):1612-23. PubMed ID: 19224950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.